P000006/S076: Titan Inflatable Penile Prosthesis
FDA’s recorded scope: implements a non-destructive in-process test method for measuring Bioflex coating thickness on kink resistant tubing
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 8 FDA records to the applicant name Coloplast Corp.. The collection includes 2 510(k) clearances. 2 entries are PMA supplements. 4 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 14, 2025 to Oct 28, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code FHW appears in 5 of the 8 linked filings. The collection spans 4 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P000006, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 1601 W. River Rd. N, Minneapolis, MN, 55411, US. Recorded on K263512, decision dated Oct 28, 2026.
Catheter, Straight; Dressing, Wound, Drug; Device, impotence, mechanical/hydraulic; Prosthesis, testicular.
FDA’s recorded scope: implements a non-destructive in-process test method for measuring Bioflex coating thickness on kink resistant tubing
FDA’s recorded scope: to increase the amount of manufacturing cleanroom space by converting existing space into a new cleanroom, along with installing a deionized water system and clean dry air system in the cleanroom
FDA’s recorded scope: to increase the amount of manufacturing cleanroom space by converting existing space into a new cleanroom, along with installing a deionized water system and clean dry air system in the cleanroom
FDA’s recorded scope: approval to incorporate a lot release strategy into the manufacturing process for the kink-resistant tubing
FDA’s recorded scope: Approval for design and packaging changes
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Luja femaleK263512 | Coloplast Corp. | 510(k) clearance | Oct 28, 2026 | FDA |
| Coloplast Corp. | 510(k) clearance | Oct 26, 2026 | FDA | |
Titan Inflatable Penile ProsthesisP000006/S076 | Coloplast Corp. | PMA supplement | Aug 13, 2026 | FDA |
Titan Inflatable Penile ProsthesisP000006/S074 | Coloplast Corp. | PMA supplement | Jul 21, 2026 | FDA |
Torosa Saline Filled Testicular ProsthesisP020003/S012 | Coloplast Corp. | PMA supplement | Jul 21, 2026 | FDA |
Titan Inflatable Penile ProsthesisP000006/S075 | Coloplast Corp. | PMA supplement | Jul 20, 2026 | FDA |
Titan Inflatable Penile Prosthesis (IPP)P000006/S072 | Coloplast Corp. | PMA supplement | Jun 2, 2026 | FDA |
Titan Inflatable Penile ProsthesisP000006/S071 | Coloplast Corp. | PMA supplement | Aug 14, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.